中国肝癌一级预防专家共识(2018)

2018-09-01 中华预防医学会 中国肿瘤.2018,27(9):660-669.

肝癌是我国最常见的恶性肿瘤之一,其病因主要包括乙型肝炎病毒(HBV)、丙型肝炎病毒感染和黄曲霉毒素,蓝藻毒素和多种可干预的个体行为方式在肝癌发生发展中也具有重要作用,实施肝癌病因的一级预防措施是在我国降低其疾病负担的重要途径。根据我国肝癌的流行病学特征,依据在我国人群中开展并获得的肝癌一级预防证据,共识探讨了乙肝疫苗接种,包括针对不同HBV 感染状态母亲的新生儿及儿童的乙肝疫苗接种程序;慢性乙型、

中文标题:

中国肝癌一级预防专家共识(2018)

发布机构:

中华预防医学会

发布日期:

2018-09-01

简要介绍:

肝癌是我国最常见的恶性肿瘤之一,其病因主要包括乙型肝炎病毒(HBV)、丙型肝炎病毒感染和黄曲霉毒素,蓝藻毒素和多种可干预的个体行为方式在肝癌发生发展中也具有重要作用,实施肝癌病因的一级预防措施是在我国降低其疾病负担的重要途径。根据我国肝癌的流行病学特征,依据在我国人群中开展并获得的肝癌一级预防证据,共识探讨了乙肝疫苗接种,包括针对不同HBV 感染状态母亲的新生儿及儿童的乙肝疫苗接种程序;慢性乙型、丙型肝炎患者的抗病毒治疗;预防和避免黄曲霉毒素及蓝藻毒素暴露;改变高危致癌风险相关的生活方式等。以期制订中国肝癌干预一级预防指南,推进我国肝癌的有效预防。 

拓展指南:肝癌相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=中国肝癌一级预防专家共识(2018))] GetToolGuiderByIdResponse(projectId=1, id=31d5f1c001636a6b, title=中国肝癌一级预防专家共识(2018), enTitle=, guiderFrom=中国肿瘤.2018,27(9):660-669., authorId=null, author=, summary=肝癌是我国最常见的恶性肿瘤之一,其病因主要包括乙型肝炎病毒(HBV)、丙型肝炎病毒感染和黄曲霉毒素,蓝藻毒素和多种可干预的个体行为方式在肝癌发生发展中也具有重要作用,实施肝癌病因的一级预防措施是在我国降低其疾病负担的重要途径。根据我国肝癌的流行病学特征,依据在我国人群中开展并获得的肝癌一级预防证据,共识探讨了乙肝疫苗接种,包括针对不同HBV 感染状态母亲的新生儿及儿童的乙肝疫苗接种程序;慢性乙型、, cover=, journalId=null, articlesId=null, associationId=174, associationName=中华预防医学会, associationIntro=中华预防医学会是全国公共卫生预防医学领域的科技工作者自愿组成并依法在民政部登记注册的非营利性、公益性、学术性法人社团,是全国性学术团体,是发展我国预防医学科学技术和预防医学事业的重要社会力量。, copyright=0, guiderPublishedTime=Sat Sep 01 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<div>肝癌是我国最常见的恶性肿瘤之一,其病因主要包括乙型肝炎病毒(HBV)、丙型肝炎病毒感染和黄曲霉毒素,蓝藻毒素和多种可干预的个体行为方式在肝癌发生发展中也具有重要作用,实施肝癌病因的一级预防措施是在我国降低其疾病负担的重要途径。根据我国肝癌的流行病学特征,依据在我国人群中开展并获得的肝癌一级预防证据,共识探讨了乙肝疫苗接种,包括针对不同HBV 感染状态母亲的新生儿及儿童的乙肝疫苗接种程序;慢性乙型、丙型肝炎患者的抗病毒治疗;预防和避免黄曲霉毒素及蓝藻毒素暴露;改变高危致癌风险相关的生活方式等。以期制订中国肝癌干预一级预防指南,推进我国肝癌的有效预防。 </div> <div><br> </div>拓展指南:<strong>与<font color=red>肝癌</font>相关指南:</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=2a5391c0016020e4" title="原发性肝癌放疗的指南推荐解读" target=_blank>原发性肝癌放疗的指南推荐解读</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=134901c0015e15a3" title="2017年版中国肝癌诊断和治疗规范解读" target=_blank>2017年版中国肝癌诊断和治疗规范解读</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=262c41c00150068d" title="原发性肝癌诊疗规范(2017 年版)更新解读" target=_blank>原发性肝癌诊疗规范(2017 年版)更新解读</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=515471c001500073" title="《原发性肝癌诊疗规范(2017年版)》解读" target=_blank>《原发性肝癌诊疗规范(2017年版)》解读</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=b57171c001a625d1" title="原发性肝癌诊疗规范(2017年版)" target=_blank>原发性肝癌诊疗规范(2017年版)</a></li> 更多信息请点击:<a href="http://www.medsci.cn/guideline/list.do?q=%E8%82%9D%E7%99%8C" target=_blank>有关肝癌更多指南</a></ul>, tagList=[TagDto(tagId=429, tagName=肝癌), TagDto(tagId=2930, tagName=一级预防)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=22, categoryName=肝病, tenant=100), CategoryDto(categoryId=35, categoryName=预防医学, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=8403, appHits=792, showAppHits=0, pcHits=5809, showPcHits=2550, likes=122, shares=34, comments=21, approvalStatus=1, publishedTime=Fri Sep 07 00:15:04 CST 2018, publishedTimeString=2018-09-01, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Fri Sep 07 00:15:04 CST 2018, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 07:20:43 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=中国肝癌一级预防专家共识(2018))])
中国肝癌一级预防专家共识(2018)
下载请点击:
评论区 (21)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1184432, encodeId=e0bf1184432a6, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40645466484, createdName=ms8000000682821176, createdTime=Fri Jan 14 23:50:17 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962046, encodeId=78ce9620465b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44412503898, createdName=124a59b0m89暂无昵称, createdTime=Fri Apr 30 23:32:25 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807344, encodeId=052380e344ba, content=努力学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1995401099, createdName=ms4000001617780766, createdTime=Mon Aug 10 21:53:06 CST 2020, time=2020-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807343, encodeId=621380e3432a, content=必须学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1995401099, createdName=ms4000001617780766, createdTime=Mon Aug 10 21:52:56 CST 2020, time=2020-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=344043, encodeId=7906344043b5, content=很好的学习机会, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/12/cd30eefc465f70dc4dad89bd57479781.jpg, createdBy=02be2318568, createdName=一天没事干, createdTime=Sat Sep 08 19:26:32 CST 2018, time=2018-09-08, status=1, ipAttribution=)]
    2022-01-14 ms8000000682821176

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1184432, encodeId=e0bf1184432a6, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40645466484, createdName=ms8000000682821176, createdTime=Fri Jan 14 23:50:17 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962046, encodeId=78ce9620465b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44412503898, createdName=124a59b0m89暂无昵称, createdTime=Fri Apr 30 23:32:25 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807344, encodeId=052380e344ba, content=努力学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1995401099, createdName=ms4000001617780766, createdTime=Mon Aug 10 21:53:06 CST 2020, time=2020-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807343, encodeId=621380e3432a, content=必须学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1995401099, createdName=ms4000001617780766, createdTime=Mon Aug 10 21:52:56 CST 2020, time=2020-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=344043, encodeId=7906344043b5, content=很好的学习机会, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/12/cd30eefc465f70dc4dad89bd57479781.jpg, createdBy=02be2318568, createdName=一天没事干, createdTime=Sat Sep 08 19:26:32 CST 2018, time=2018-09-08, status=1, ipAttribution=)]
    2021-04-30 124a59b0m89暂无昵称

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1184432, encodeId=e0bf1184432a6, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40645466484, createdName=ms8000000682821176, createdTime=Fri Jan 14 23:50:17 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962046, encodeId=78ce9620465b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44412503898, createdName=124a59b0m89暂无昵称, createdTime=Fri Apr 30 23:32:25 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807344, encodeId=052380e344ba, content=努力学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1995401099, createdName=ms4000001617780766, createdTime=Mon Aug 10 21:53:06 CST 2020, time=2020-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807343, encodeId=621380e3432a, content=必须学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1995401099, createdName=ms4000001617780766, createdTime=Mon Aug 10 21:52:56 CST 2020, time=2020-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=344043, encodeId=7906344043b5, content=很好的学习机会, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/12/cd30eefc465f70dc4dad89bd57479781.jpg, createdBy=02be2318568, createdName=一天没事干, createdTime=Sat Sep 08 19:26:32 CST 2018, time=2018-09-08, status=1, ipAttribution=)]
    2020-08-10 ms4000001617780766

    努力学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1184432, encodeId=e0bf1184432a6, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40645466484, createdName=ms8000000682821176, createdTime=Fri Jan 14 23:50:17 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962046, encodeId=78ce9620465b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44412503898, createdName=124a59b0m89暂无昵称, createdTime=Fri Apr 30 23:32:25 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807344, encodeId=052380e344ba, content=努力学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1995401099, createdName=ms4000001617780766, createdTime=Mon Aug 10 21:53:06 CST 2020, time=2020-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807343, encodeId=621380e3432a, content=必须学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1995401099, createdName=ms4000001617780766, createdTime=Mon Aug 10 21:52:56 CST 2020, time=2020-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=344043, encodeId=7906344043b5, content=很好的学习机会, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/12/cd30eefc465f70dc4dad89bd57479781.jpg, createdBy=02be2318568, createdName=一天没事干, createdTime=Sat Sep 08 19:26:32 CST 2018, time=2018-09-08, status=1, ipAttribution=)]
    2020-08-10 ms4000001617780766

    必须学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1184432, encodeId=e0bf1184432a6, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40645466484, createdName=ms8000000682821176, createdTime=Fri Jan 14 23:50:17 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962046, encodeId=78ce9620465b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44412503898, createdName=124a59b0m89暂无昵称, createdTime=Fri Apr 30 23:32:25 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807344, encodeId=052380e344ba, content=努力学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1995401099, createdName=ms4000001617780766, createdTime=Mon Aug 10 21:53:06 CST 2020, time=2020-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807343, encodeId=621380e3432a, content=必须学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1995401099, createdName=ms4000001617780766, createdTime=Mon Aug 10 21:52:56 CST 2020, time=2020-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=344043, encodeId=7906344043b5, content=很好的学习机会, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/12/cd30eefc465f70dc4dad89bd57479781.jpg, createdBy=02be2318568, createdName=一天没事干, createdTime=Sat Sep 08 19:26:32 CST 2018, time=2018-09-08, status=1, ipAttribution=)]
    2018-09-08 一天没事干

    很好的学习机会

    0